Business Description
Cardinal Health Inc
NAICS : 424210
SIC : 5122
ISIN : US14149Y1082
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.64 | |||||
Equity-to-Asset | -0.07 | |||||
Debt-to-Equity | -1.79 | |||||
Debt-to-EBITDA | 3.45 | |||||
Interest Coverage | 29.76 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.15 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.5 | |||||
3-Year EPS without NRI Growth Rate | 2 | |||||
3-Year FCF Growth Rate | 18.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.03 | |||||
Future 3-5Y Total Revenue Growth Rate | 9 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 29.62 | |||||
9-Day RSI | 29.09 | |||||
14-Day RSI | 30.83 | |||||
6-1 Month Momentum % | 5.12 | |||||
12-1 Month Momentum % | 28.12 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.98 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.1 | |||||
Days Inventory | 29.2 | |||||
Days Sales Outstanding | 18.85 | |||||
Days Payable | 53.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.03 | |||||
Dividend Payout Ratio | 0.28 | |||||
3-Year Dividend Growth Rate | 1 | |||||
Forward Dividend Yield % | 2.05 | |||||
5-Year Yield-on-Cost % | 2.17 | |||||
3-Year Average Share Buyback Ratio | 5 | |||||
Shareholder Yield % | 7.92 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 3.35 | |||||
Operating Margin % | 0.94 | |||||
Net Margin % | 0.25 | |||||
FCF Margin % | 0.91 | |||||
ROE % | Neg. Equity | |||||
ROA % | 1.24 | |||||
ROIC % | 12.06 | |||||
ROC (Joel Greenblatt) % | 40.88 | |||||
ROCE % | 10.58 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 44.25 | |||||
Forward PE Ratio | 13.21 | |||||
PE Ratio without NRI | 13.87 | |||||
Shiller PE Ratio | 99.57 | |||||
Price-to-Owner-Earnings | 23.39 | |||||
PS Ratio | 0.11 | |||||
Price-to-Free-Cash-Flow | 12.42 | |||||
Price-to-Operating-Cash-Flow | 9.81 | |||||
EV-to-EBIT | 26.14 | |||||
EV-to-Forward-EBIT | 12.31 | |||||
EV-to-EBITDA | 15.35 | |||||
EV-to-Forward-EBITDA | 9.73 | |||||
EV-to-Revenue | 0.12 | |||||
EV-to-Forward-Revenue | 0.12 | |||||
EV-to-FCF | 12.96 | |||||
Price-to-Projected-FCF | 1.05 | |||||
Price-to-Median-PS-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | 3.83 | |||||
FCF Yield % | 8.28 | |||||
Forward Rate of Return (Yacktman) % | 3.26 |